K +31
|
K 3x +31
|
|
3iqkA
|
Human carbonic anhydrase ii h64a complexed with thioxolone hydrolysis products
|
S +31
|
S 23x +31
|
|
1bnnA
|
Carbonic anhydrase ii inhibitor
|
S +31
|
S 3x +31
|
|
1ttmA
|
Human carbonic anhydrase ii complexed with 667-coumate
|
S +31
|
S 3x +31
|
|
1azmA
|
Drug-protein interactions: structure of sulfonamide drug complexed with human carbonic anhydrase i
|
S +31
|
S 7x +31
|
|
1bv3A
|
Human carbonic anhydrase ii complexed with urea
|
S +31
|
S 3x +31
|
|
1rzbA
|
X-ray analysis of metal substituted human carbonic anhydrase ii derivatives
|
K +31
|
K 3x +31
|
|
1cakA
|
Structural analysis of the zinc hydroxide-thr 199-glu 106 hydrogen bonding network in human carbonic anhydrase ii
|
S +31
|
S 1x +31
|
|
12caA
|
Altering the mouth of a hydrophobic pocket. structure and kinetics of human carbonic anhydrase ii mutants at residue val-121
|
S +31
|
S 3x +31
|
|
4pyyA
|
Crystal structure of human carbonic anhydrase isozyme ii with inhibitor
|
S +31
|
S 5x +31
|
|
1ccsA
|
Structure-assisted redesign of a protein-zinc binding site with femtomolar affinity
|
S +31
|
S 11x +31
|
|
1bn1A
|
Carbonic anhydrase ii inhibitor
|
S +31
|
S 7x +31
|
|
2hocA
|
Crystal structure of the human carbonic anhydrase ii in complex with the 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide inhibitor
|
S +31
|
S 5x +31
|
|
1cniA
|
X-ray crystallographic studies of engineered hydrogen bond networks in a protein-zinc binding site
|
K +31
|
K 4x +31
|
|
3ml5A
|
Crystal structure of the c183s/c217s mutant of human ca vii in complex with acetazolamide
|
K +31
|
K 3x +31
|
|
3mnuA
|
Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron containing aromatic sulfamide with mammalian isoforms i-xv
|
K +31
|
K 3x +31
|
4
|
2nnoA
|
Structure of inhibitor binding to carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
3dc3A
|
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
|
K +31
|
K 3x +31
|
|
1caoA
|
Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions
|
S +31
|
S 3x +31
|
|
1th9A
|
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii
|
K +31
|
K 3x +31
|
|
3konA
|
Crystal structure of cobalt (ii) human carbonic anhydrase ii at ph 11.0
|
S +31
|
S 3x +31
|
|
3d92A
|
Human carbonic anhydrase ii bound with substrate carbon dioxide
|
K +31
|
K 3x +31
|
|
2nwoA
|
Structural and kinetic effect of hydrophobic mutations in the active site of human carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
2f14A
|
Tne crystal structure of the human carbonic anhydrase ii in complex with a fluorescent inhibitor
|
S +31
|
S 1x +31
|
|
2hfwA
|
Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase iii
|
S +31
|
S 3x +31
|
|
3mnaA
|
The crystal structure of human carbonic anhydrase ii in complex with a 1,3,5-triazine-substituted benzenesulfonamide inhibitor
|
S +31
|
S 3x +31
|
|
1j9wA
|
Solution structure of the cai michigan 1 variant
|
K +31
|
K 5x +31
|
|
1cnjA
|
X-ray crystallographic studies of engineered hydrogen bond networks in a protein-zinc binding site
|
K +31
|
K 3x +31
|
|
3mhcA
|
Crystal structure of human cabonic anhydrase ii in adduct with an adamantyl analogue of acetazolamide in a novel hydrophobic binding pocket
|
S +31
|
S 3x +31
|
|
3mzcA
|
Human carbonic ahydrase ii in complex with a benzenesulfonamide inhibitor
|
S +31
|
S 23x +31
|
|
1if4A
|
Carbonic anhydrase ii complexed with 4-fluorobenzenesulfonamide
|
S +31
|
S 15x +31
|
|
1i9nA
|
Carbonic anhydrase ii (f131v) complexed with 4-(aminosulfonyl)-n-[(2,5-difluorophenyl)methyl]-benzamide
|
S +31
|
S 15x +31
|
|
1if6A
|
Carbonic anhydrase ii complexed with 3,5-difluorobenzenesulfonamide
|
S +31
|
S 7x +31
|
|
1g46A
|
Carbonic anhydrase ii (f131v) complexed with 4-(aminosulfonyl)-n-[(2,3-difluorophenyl)methyl]-benzamide
|
S +31
|
S 3x +31
|
|
3igpA
|
Structure of inhibitor binding to carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
3r17B
|
Hcarbonic anhydrase ii bound to n-(2-fluoro.4-sulfamoylphenyl)-2-(thiophen-2-yl) acetamide
|
S +31
|
S 10x +31
|
|
4ca2A
|
Engineering the hydrophobic pocket of carbonic anhydrase ii
|
S +31
|
S 6x +31
|
|
3ieoA
|
The coumarin-binding site in carbonic anhydrase: the antiepileptic lacosamide as an example
|
S +31
|
S 11x +31
|
|
3nj9A
|
Crystal structure of carbonic anhydrase ii in complex with a nir inhibitor
|
S +31
|
S 3x +31
|
|
2cbdA
|
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes
|
S +31
|
S 3x +31
|
|
3f4xA
|
Carbonic anhydrase inhibitors. comparison of chlorthalidone and indapamide x-ray crystal structures in adducts with isozyme ii: when three water molecules make the difference
|
S +31
|
S 3x +31
|
|
2wehA
|
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors
|
K +31
|
K 3x +31
|
|
3dazA
|
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
|
S +31
|
S 3x +31
|
|
3dc9A
|
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
|
S +31
|
S 3x +31
|
4
|
2nnvA
|
Structure of inhibitor binding to carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
2fw4A
|
Carbonic anhydrase activators. the first x-ray crystallographic study of an activator of isoform i, structure with l-histidine.
|
S +31
|
S 7x +31
|
|
1g3zA
|
Carbonic anhydrase ii (f131v)
|
S +31
|
S 3x +31
|
|
1zscA
|
Carbonic anhydrase ii mutant e117q, holo form
|
S +31
|
S 11x +31
|
|
1bn3A
|
Carbonic anhydrase ii inhibitor
|
S +31
|
S 3x +31
|
|
2cbaA
|
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes
|
S +31
|
S 3x +31
|
|
1rj5A
|
Crystal structure of the extracellular domain of murine carbonic anhydrase xiv
|
S +31
|
S 3x +31
|
|
2eu3A
|
Human carbonic anhydrase ii in complex with novel inhibitors
|
S +31
|
S 7x +31
|
|
1bnqA
|
Carbonic anhydrase ii inhibitor
|
S +31
|
S 3x +31
|
|
3mnkA
|
Human carbonic anhydrase ii mutant k170h
|
K +31
|
K 3x +31
|
|
2vvbX
|
Human carbonic anhydrase ii in complex with bicarbonate
|
K +31
|
K 3x +31
|
|
3kkxA
|
Neutron structure of human carbonic anhydrase ii
|
K +31
|
K 3x +31
|
|
3hknA
|
Human carbonic anhydrase ii in complex with (2,3,4,6-tetra-o-acetyl-beta-d-galactopyranosyl) -(1-4)-1,2,3,6-tetra-o-acetyl-1-thio-beta-d-glucopyranosylsulfonamide
|
S +31
|
S 3x +31
|
|
3hljA
|
Crystal structure of human carbonic anhydrase isozyme ii with 3-methylthiobenzimidazo[1,2-c][1,2,3]thiadiazol-7-sulfonamide
|
S +31
|
S 3x +31
|
|
3oikA
|
Human carbonic anhydrase ii mutant a65s, n67q (ca ix mimic) bound by 2-ethylestradiol 3,17-o,o-bis-sulfamate
|
S +31
|
S 3x +31
|
|
3mnjA
|
Human carbonic anhydrase ii mutant k170e
|
K +31
|
K 3x +31
|
|
2fnnA
|
Activation of human carbonic anhydrase ii by exogenous proton donors
|
S +31
|
S 3x +31
|
4
|
2x7sA
|
Structures of human carbonic anhydrase ii inhibitor complexes reveal a second binding site for steroidal and non-steroidal inhibitors.
|
K +31
|
K 3x +31
|
|
1ugdA
|
Human carbonic anhydrase ii[hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by ser (a65s)
|
S +31
|
S 3x +31
|
|
1hcbA
|
Enzyme-substrate interactions: structure of human carbonic anhydrase i complexed with bicarbonate
|
S +31
|
S 3x +31
|
|
3mniA
|
Human carbonic anhydrase ii mutant k170d
|
S +31
|
S 3x +31
|
4
|
2nngA
|
Structure of inhibitor binding to carbonic anhydrase ii
|
K +31
|
K 3x +31
|
|
3gz0A
|
Apo-human carbonic anhydrase ii revisited: implications of the loss of a metal in protein structure, stability and solvent network
|
S +31
|
S 1x +31
|
|
1cveA
|
Structural consequences of redesigning a protein-zinc binding site
|
S +31
|
S 3x +31
|
4
|
2foqA
|
Human carbonic anhydrase ii complexed with two-prong inhibitors
|
S +31
|
S 11x +31
|
|
1bn4A
|
Carbonic anhydrase ii inhibitor
|
S +31
|
S 3x +31
|
|
1yo0A
|
Proton transfer from his200 in human carbonic anhydrase ii
|
S +31
|
S 11x +31
|
|
1heaA
|
Carbonic anhydrase ii (carbonate dehydratase) (hca ii) (e.c.4.2.1.1) mutant with leu 198 replaced by arg (l198r)
|
K +31
|
K 3x +31
|
|
1z97A
|
Human carbonic anhydrase iii: structural and kinetic study of catalysis and proton transfer.
|
K +31
|
K 3x +31
|
|
1fsqA
|
X-ray crystal structure of cobalt-bound f93s/f95l/w97m carbonic anhydrase (caii) variant
|
S +31
|
S 3x +31
|
|
1te3X
|
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii
|
S +31
|
S 11x +31
|
|
1fqlA
|
X-ray crystal structure of zinc-bound f95m/w97v carbonic anhydrase (caii) variant
|
S +31
|
S 3x +31
|
|
1hugA
|
Differences in anionic inhibition of human carbonic anhydrase i revealed from the structures of iodide and gold cyanide inhibitor complexes
|
S +31
|
S 3x +31
|
4
|
3fe4A
|
Crystal structure of human carbonic anhydrase vi
|
S +31
|
S 3x +31
|
|
3bl1A
|
Carbonic anhydrase inhibitors. sulfonamide diuretics revisited old leads for new applications
|
K +31
|
K 7x +31
|
|
1ze8A
|
Carbonic anhydrase ii in complex with a membrane-impermeant sulfonamide inhibitor
|
S +31
|
S 3x +31
|
|
1lgdA
|
Crystal structure analysis of hca ii mutant t199p in complex with bicarbonate
|
S +31
|
S 7x +31
|
|
7ca2A
|
Engineering the hydrophobic pocket of carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
1huhA
|
Differences in anionic inhibition of human carbonic anhydrase i revealed from the structures of iodide and gold cyanide inhibitor complexes
|
S +31
|
S 11x +31
|
|
1yddA
|
Structural basis of inhibitor affinity to variants of human carbonic anhydrase ii
|
S +31
|
S 11x +31
|
|
2gd8A
|
Crystal structure analysis of the human carbonic anhydrase ii in complex with a 2-substituted estradiol bis-sulfamate
|
S +31
|
S 3x +31
|
|
3mwoA
|
Human carbonic anhydrase ii in a doubled monoclinic cell: a re-determination
|
S +31
|
S 3x +31
|
|
1cvbA
|
Structural and functional importance of a conserved hydrogen bond network in human carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
2vvaX
|
Human carbonic anhydrase in complex with co2
|
K +31
|
K 1x +31
|
|
2eu2A
|
Human carbonic anhydrase ii in complex with novel inhibitors
|
K +31
|
K 3x +31
|
|
3m1qA
|
Carbonic anhydrase ii mutant w5c-h64c with opened disulfide bond
|
K +31
|
K 3x +31
|
|
3myqA
|
Crystal structure of human carbonic anhydrase isozyme ii with 2-chloro-5-[(1h-imidazo[4,5-c]quinolin-2-ylsulfanyl)acetyl]benzenesulfonamide
|
S +31
|
S 3x +31
|
|
1zsbA
|
Carbonic anhydrase ii mutant e117q, transition state analogue acetazolamide
|
K +31
|
K 3x +31
|
4
|
2nnsA
|
Structure of inhibitor binding to carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
1ugaA
|
Human carbonic anhydrase ii[hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by phe (a65f)
|
S +31
|
S 11x +31
|
|
1oknA
|
Carbonic anhydrase ii complex with the 1okn inhibitor 4-sulfonamide-[1-(4-n-(5-fluorescein thiourea)butane)]
|
S +31
|
S 3x +31
|
|
1cahA
|
Structure of cobalt carbonic anhydrase complexed with bicarbonate
|
S +31
|
S 3x +31
|
|
1fr4A
|
X-ray crystal structure of copper-bound f93i/f95m/w97v carbonic anhydrase (caii) variant
|
K +31
|
K 3x +31
|
|
3r16A
|
Human caii bound to n-(4-sulfamoylphenyl)-2-(thiophen-2-yl) acetamide
|
S +31
|
S 3x +31
|
|
3k7kA
|
Crystal structure of the complex between carbonic anhydrase ii and anions
|
S +31
|
S 3x +31
|
|
3ni5A
|
Carbonic anhydrase inhibitor: c1 family
|
S +31
|
S 3x +31
|
|
1fqrA
|
X-ray crystal structure of cobalt-bound f93i/f95m/w97v carbonic anhydrase (caii) variant
|
K +31
|
K 3x +31
|
|
2fnmA
|
Activation of human carbonic anhdyrase ii by exogenous proton donors
|
S +31
|
S 3x +31
|
|
1xq0A
|
Structure of human carbonic anhydrase ii with 4-[(3-bromo-4-o-sulfamoylbenzyl)(4-cyanophenyl)amino]-4h-[1,2,4]-triazole
|
S +31
|
S 11x +31
|
|
1bnwA
|
Carbonic anhydrase ii inhibitor
|
K +31
|
K 3x +31
|
|
1razA
|
The structure of human carbonic anhydrase ii in complex with bromide and azide
|
S +31
|
S 3x +31
|
|
1cazA
|
Wild-type and e106q mutant carbonic anhydrase complexed with acetate
|
S +31
|
S 3x +31
|
|
1t9nA
|
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii
|
S +31
|
S 22x +31
|
|
5ca2A
|
Conformational mobility of his-64 in the thr-200 (right arrow) ser mutant of human carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
5cacA
|
Refined structure of human carbonic anhydrase ii at 2.0 angstroms resolution
|
S +31
|
S 3x +31
|
|
2fmzA
|
Carbonic anhydrase activators. activation of isoforms i, ii, iv, va, vii and xiv with l- and d- phenylalanine, structure with d-phenylalanine.
|
S +31
|
S 11x +31
|
|
2hncA
|
Crystal structure of the human carbonic anhydrase ii in complex with the 5-amino-1,3,4-thiadiazole-2-sulfonamide inhibitor.
|
S +31
|
S 3x +31
|
|
2povA
|
The crystal structure of the human carbonic anhydrase ii in complex with 4-amino-6-chloro-benzene-1,3-disulfonamide
|
K +31
|
K 11x +31
|
|
1g0fA
|
Site-specific mutant (his64 replaced with ala) of human carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
3hkuA
|
Human carbonic anhydrase ii in complex with topiramate
|
S +31
|
S 3x +31
|
|
3dvdA
|
X-ray crystal structure of mutant n62d of human carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
1h9nA
|
H119n carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
1v9iC
|
Crystal structure analysis of the site specific mutant (q253c) of bovine carbonic anhydrase ii
|
S +31
|
S 1x +31
|
|
1cvhA
|
Structural consequences of redesigning a protein-zinc binding site
|
S +31
|
S 1x +31 +31
|
|
1koqA
|
Neisseria gonorrhoeae carbonic anhydrase
|
K +31
|
K 3x +31
|
|
2wd3A
|
Highly potent first examples of dual aromatase-steroid sulfatase inhibitors based on a biphenyl template
|
S +31
|
S 3x +31
|
|
2it4A
|
X ray structure of the complex between carbonic anhydrase i and the phosphonate antiviral drug foscarnet
|
S +31
|
S 3x +31
|
|
1g6vA
|
Complex of the camelid heavy-chain antibody fragment cab-ca05 with bovine carbonic anhydrase
|
S +31
|
S 6x +31
|
|
1dcaA
|
Structure of an engineered metal binding site in human carbonic anhydrase ii reveals the architecture of a regulatory cysteine switch
|
K +31
|
K 3x +31
|
|
3n0nA
|
Crystal structure of human carbonic anhydrase ii in complex with a benzenesulfonamide inhibitor
|
S +31
|
S 3x +31
|
|
3m5tA
|
Fragment tethered to carbonic anhydrase ii h64c mutant
|
S +31
|
S 7x +31
|
|
1g45A
|
Carbonic anhydrase ii (f131v) complexed with 4-(aminosulfonyl)-n-[(2-fluorophenyl)methyl]-benzamide
|
S +31
|
S 22x +31
|
|
1bntA
|
Carbonic anhydrase ii inhibitor
|
S +31
|
S 11x +31
|
|
1muaA
|
Structure and energetics of a non-proline cis-peptidyl linkage in an engineered protein
|
S +31
|
S 3x +31
|
|
2cabA
|
Structure, refinement and function of carbonic anhydrase isozymes. refinement of human carbonic anhydrase i
|
S +31
|
S 3x +31
|
|
1bzmA
|
Drug-protein interactions: structure of sulfonamide drug complexed with human carbonic anhydrase i
|
S +31
|
S 15x +31
|
|
1am6A
|
Carbonic anhydrase ii inhibitor: acetohydroxamate
|
K +31
|
K 3x +31
|
|
2pouA
|
The crystal structure of the human carbonic anhydrase ii in complex with 4,5-dichloro-benzene-1,3-disulfonamide
|
S +31
|
S 3x +31
|
|
3dcsA
|
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
|
S +31
|
S 15x +31
|
|
1g53A
|
Carbonic anhydrase ii complexed with 4-(aminosulfonyl)-n-[(2,6-difluorophenyl)methyl]-benzamide
|
S +31
|
S 3x +31
|
|
1eouA
|
Crystal structure of human carbonic anhydrase ii complexed with an anticonvulsant sugar sulfamate
|
S +31
|
S 3x +31
|
|
1oq5A
|
Carbonic anhydrase ii in complex with nanomolar inhibitor
|
S +31
|
S 3x +31
|
|
1rayA
|
The structure of human carbonic anhydrase ii in complex with bromide and azide
|
S +31
|
S 3x +31
|
|
1caiA
|
Structural analysis of the zinc hydroxide-thr 199-glu 106 hydrogen bonding network in human carbonic anhydrase ii
|
S +31
|
S 3x +31
|
|
3n2pA
|
Crystal structure of human carbonic anhydrase ii in complex with a benzenesulfonamide inhibitor
|
S +31
|
S 3x +31
|
|
1dcbA
|
Structure of an engineered metal binding site in human carbonic anhydrase ii reveals the architecture of a regulatory cysteine switch
|
S +31
|
S 7x +31
|
|
1g48A
|
Carbonic anhydrase ii (f131v) complexed with 4-(aminosulfonyl)-n-[(2,6-difluorophenyl)methyl]-benzamide
|
S +31
|
S 3x +31
|
|
3hkqA
|
Human carbonic anhydrase ii in complex with 1-s-d-galactopyranosylsulfonamide
|
S +31
|
S 3x +31
|
|
3dd0A
|
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
|
S +31
|
S 3x +31
|
|
1rj6A
|
Crystal structure of the extracellular domain of murine carbonic anhydrase xiv in complex with acetazolamide
|
S +31
|
S 3x +31
|
|
3hs4A
|
Human carbonic anhydrase ii complexed with acetazolamide
|
S +31
|
S 7x +31
|
|
3m1jA
|
The crystal structure of a nami a-carbonic anhydrase ii adduct discloses the mode of action of this novel anticancer metallodrug
|
S +31
|
S 3x +31
|
|
3dcwA
|
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties
|
K +31
|
K 3x +31
|
|
2fnkA
|
Activation of human carbonic anhydrase ii by exogenous proton donors
|
S +31
|
S 11x +31
|
|
1okmA
|
Carbonic anhydrase ii complex with the 1okm inhibitor 4-sulfonamide-[1-(4-aminobutane)]benzamide
|
S +31
|
S 11x +31
|
|
2q1bA
|
Carbonic anhydrase ii in complex with saccharin
|
S +31
|
S 3x +31
|
|
1cayA
|
Wild-type and e106q mutant carbonic anhydrase complexed with acetate
|